Approaches to the description of patterns of care after colitis diagnosis in melanoma patients treated with immune checkpoint inhibitors (ICIs)

被引:0
|
作者
Pan, Xianying [1 ]
Kulkarni, Vishal [2 ]
Pathak, Raminder [1 ]
Monda, Stefano [1 ]
Hasan, Imran [1 ]
机构
[1] Bristol Myers Squibb, New York, NY USA
[2] Mu Sigma, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
110
引用
收藏
页码:39 / 39
页数:1
相关论文
共 50 条
  • [1] COLITIS DIAGNOSIS IN MELANOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI) IN REAL-WORLD SETTINGS: TIMING OF ONSET AND PATTERNS OF CARE
    Pan, Xianying
    Yadav, Suraj
    Pathak, Raminder
    Cheng, Ben
    Monda, Stefano
    Hasan, Imran
    Lawlor, Garrett
    GASTROENTEROLOGY, 2024, 166 (05) : S1034 - S1034
  • [2] Treatment with immune checkpoint inhibitors (ICIs) and the occurrence of colitis among patients with melanoma in the United States
    Pan, Xianying
    Verma, Devashish
    Zhang, Jiayin
    Pathak, Raminder
    Monda, Stefano
    Ma, Xiaomei
    CANCER RESEARCH, 2023, 83 (07)
  • [3] PREDICTING PRIMARY RESISTANCE AND EXPLORING MECHANISMS IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICIS)
    Long, Georjna A. O.
    Tang, Tracy
    Apfel, Abraham
    Paulucci, David
    Chasalow, Scott
    Tenney, Daniel
    Fusaro, Gina
    Schadendorf, Dirk
    Tawbi, Hussein
    Hodi, F. Stephen
    Thakkar, Pratik
    Larkin, James
    Wolchok, Jedd
    Wind-Rotolo, Megan
    Huang, Shu-Pang
    Mohr, Peter
    Robert, Caroline
    Hoeller, Christoph
    Grob, Jean-Jacque
    Gogas, Helen
    Weber, Jeffrey
    Chang, Han
    Moss, Rebecca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A639 - A640
  • [4] Enteritis without colitis in patients treated with immune checkpoint inhibitors: a tricky diagnosis
    Sokal, Aurelien
    de Chou, Camille Salle
    Delyon, Julie
    Roche, Brigitte
    Lourenco, Nelson
    Lebbe, Celeste
    Baroudjian, Barouyr
    MELANOMA RESEARCH, 2018, 28 (05) : 483 - 484
  • [5] Association of corticosteroid (CS) exposure with treatment failure in patients (pts) with advanced melanoma treated with immune checkpoint inhibitors (ICIs)
    Le, H. M. L.
    Pozas Perez, J.
    San Roman Gil, M. V.
    Serrano Domingo, J. J.
    Larkin, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S691 - S691
  • [6] Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma.
    Tie, Emilia Nan
    Lai-Kwon, Julia Elizabeth
    Na, Lumine
    Rtshiladze, Michael Alexander
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina V.
    McArthur, Grant A.
    Sandhu, Shahneen Kaur
    Saw, Robyn
    Walpole, Euan Thomas
    Menzies, Alexander M.
    Smithers, B. Mark
    Gyorki, David E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [8] Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors
    Asher, Nethanel
    Marom, Edith M.
    Ben-Betzalel, Guy
    Baruch, Erez Nissim
    Steinberg-Silman, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Markel, Gal
    ONCOLOGIST, 2019, 24 (05): : 640 - 647
  • [9] Clinical outcome of immune related hepatitis (IrHep) in patients with advanced melanoma (AM) treated with single agent or combination immune checkpoint inhibitors (ICIs)
    Shah, N.
    Puthiamadathil, J.
    Serzan, M. T.
    Belouali, A.
    Kelly, W. J.
    Ma, B.
    Blackburn, M.
    Knoedler, A.
    OchoaGonzaelz, S.
    Janni, M.
    Madhavan, S.
    Gibney, G. T.
    Atkins, M. B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs)
    He, Jiasen
    John, Ida
    Afridi, Faraz
    Sun, Mianen
    Wang, Yinghong
    Roth, Michael
    McQuade, Jennifer Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)